BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30088064)

  • 21. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
    Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
    Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
    Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
    Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
    Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
    Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
    Pinker-Domenig K; Bogner W; Gruber S; Bickel H; Duffy S; Schernthaner M; Dubsky P; Pluschnig U; Rudas M; Trattnig S; Helbich TH
    Eur Radiol; 2012 Feb; 22(2):322-30. PubMed ID: 21913060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of contrast-enhanced digital mammography and contrast enhanced tomosynthesis--Comparison to contrast-enhanced breast MRI.
    Chou CP; Lewin JM; Chiang CL; Hung BH; Yang TL; Huang JS; Liao JB; Pan HB
    Eur J Radiol; 2015 Dec; 84(12):2501-8. PubMed ID: 26456307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization.
    Thomassin-Naggara I; Trop I; Chopier J; David J; Lalonde L; Darai E; Rouzier R; Uzan S
    Radiology; 2011 Oct; 261(1):69-79. PubMed ID: 21771958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management.
    Lee SE; Lee JH; Han K; Kim EK; Kim MJ; Moon HJ; Yoon JH; Park VY
    Eur Radiol; 2020 May; 30(5):2773-2781. PubMed ID: 32006168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI.
    Mori N; Tsuchiya K; Sheth D; Mugikura S; Takase K; Katscher U; Abe H
    Eur Radiol; 2019 Apr; 29(4):1778-1786. PubMed ID: 30255252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms.
    Zhang R; Xu M; Zhou C; Ding X; Lu H; Ge M; Du L; Bu Y
    Quant Imaging Med Surg; 2022 Aug; 12(8):4069-4080. PubMed ID: 35919041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
    Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
    J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
    Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
    Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
    Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
    Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
    Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
    Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benign (BI-RADS 2) lesions in breast MRI.
    Spick C; Szolar DH; Tillich M; Reittner P; Preidler KW; Baltzer PA
    Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies.
    Pötsch N; Dietzel M; Kapetas P; Clauser P; Pinker K; Ellmann S; Uder M; Helbich T; Baltzer PAT
    Eur Radiol; 2021 Aug; 31(8):5866-5876. PubMed ID: 33744990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.